Publication of WID Tests in Nature Communications

Our latest research, out in Nature Communications today, assesses the epigenetic footprint in cervical screening samples to detect and risk predict breast and ovarian cancer and has the potential to change the future of personalised preventive medicine.

Find a video outlining the principle of the test below, or read the research:

EUTOPS Institute

Our vision is to integrate cutting-edge research in systems biology and oncology to enable real-world implementation of the concepts of P4 medicine (predictive, preventive, personalised and participatory) and drastically reduce cancer mortality.

Meet the Team

We are a dynamic and international team with wide range of expertise.